Electronic and Lab Pre-screening of New Rheumatology Patients With Rheumatoid Arthritis

NCT03843619 | Unknown

• 1 other identifier: R-17015
• Study Type: observational
• Target: 200
• Locations: 0 countries
• Sites: N/A

Brief Summary

By forming the foundation of a delivery system that integrates primary care (PC) and rheumatology, this initiative strives to strengthen the roles of both primary care and rheumatology practices as they co-manage patients in a quality care delivery system. Importantly, it strives to fill an unmet need, the rapid evaluation by Primary Care providers; the appropriate and timely referral of inflammatory disease patients to a rheumatologist; and the implementation of early aggressive therapy in the management of patients with rheumatoid arthritis (RA) with tight control. Given the call for improved quality, value, and demonstration of results\[1\], this initiative uses the tenets of National Center for Quality Assurance's Patient Centered Specialty Program\[1\] (PCSP) and it successfully masters and streamlines coordination of care.

Conditions

Rheumatoid Arthritis; Inflammatory Arthritis

Outcome Measures

Primary Outcomes (1)

• To increase referral efficiencies through an electronic system to decrease the timeline prior

  Mean and median time (in days) to the first rheumatology visit from PCP referral for both cohorts

  One year enrollment period

Secondary Outcomes (3)

• To assess difference in disease activity progression using Clinical Disease Activity Index (CDAI) at both 12 and 24 months.

  One year enrollment period with two year follow-up period.

• To assess difference in disease activity progression using Routine Assessment of Patient Index Data (RAPID3) at both 12 and 24 months.

  One year enrollment period with two year follow-up period.

• To assess radiographic progression using sharp scores in the electronically referred cohorts versus the traditional cohort.

  One year enrollment period with two year follow-up period.

Study Arms (2)

Non-E-referral

Patients who are referred in the traditional manner between two separate organizations.

E-referral

Patients who are referred in an automated manner between two separate organizations.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

All patients referred to a rheumatologist for inflammatory arthritis.

You may qualify if:

• First ever referral to a rheumatologist.

Sponsors & Collaborators

• Arthritis Northwest PLLC: lead
• Bristol-Myers Squibb: collaborator
• Discus Analytics LLC: collaborator

MeSH Terms

Conditions

Arthritis, Rheumatoid; Arthritis

Condition Hierarchy (Ancestors)

Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Connective Tissue Diseases; Skin and Connective Tissue Diseases; Autoimmune Diseases; Immune System Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 22, 2019
• First Posted: February 18, 2019
• Study Start: February 28, 2019
• Primary Completion: March 31, 2022
• Study Completion: March 31, 2022
• Last Updated: February 18, 2019

Record last verified: 2019-02